We analyzed the available evidence on SRK-015 and muscle mass in mice, and what we’ve found so far is that one study reported a single injection of SRK-015 increased muscle mass by 17.5% and prevented muscle loss induced by dexamethasone, without lowering muscle quality [1]. All 18.0 supporting assertions we reviewed align with this single observation, and no studies or claims contradicted it. This suggests that, under the specific conditions of that study, SRK-015 may have an effect on muscle growth and protection against atrophy in mice. Dexamethasone is a drug known to cause muscle wasting, so the fact that SRK-015 appeared to block that effect is notable. The 17.5% increase in muscle mass is a measurable change, and the note that muscle quality was not reduced adds context — meaning the added tissue wasn’t just swelling or fat, but likely functional muscle. However, this conclusion is based on only one set of experimental results. We don’t know how consistent this effect is across different mouse strains, doses, or time frames. We also don’t know if the same result would appear in other models of muscle loss, or if the effect lasts beyond the observation period. The evidence we’ve reviewed leans toward SRK-015 having a positive impact on muscle mass in this specific setting, but we can’t say whether this applies broadly or would translate to other animals or humans. For now, the data is limited to one scenario in mice, and while it’s promising, more studies would be needed to understand how reliable or repeatable this outcome is. If you’re tracking SRK-015 for muscle health, this early finding is worth watching — but it’s still just one piece of a much larger puzzle.